New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
09:06 EDTAVNRAvanir's migraine candidate New Drug Application accepted by FDA
Avanir Pharmaceuticals' New Drug Application of AVP-825, its investigational drug-device combination product for the acute treatment of migraine, has been accepted by the FDA. The Prescription Drug User Fee Act V goal date is November 26.
News For AVNR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:10 EDTAVNRAvanir downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
December 12, 2014
11:01 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
December 10, 2014
15:25 EDTAVNRNotable companies reporting after market close
Subscribe for More Information
December 8, 2014
10:20 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
05:50 EDTAVNRStocks with implied volatility movement; AVNR MNKD
Subscribe for More Information
December 5, 2014
10:40 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use